Can-Fite BioPharma Total Current Liabilities

The latest total current liabilities for CANF.TA is $2.2M as of June 2026. That compares with $2.1M in the prior-year period — up 5.0% year over year. Investors often review this figure alongside Can-Fite BioPharma's historical trend and sector peers before judging valuation or financial health.

Over the past year, CANF.TA's total current liabilities moved from $2.1M to $2.2M — a 5.0% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Can-Fite BioPharma's operating scale or balance-sheet position.

A total current liabilities figure of $2.2M for CANF.TA is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting CANF.TA's total current liabilities ($2.2M), review year-over-year change from $2.1M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Can-Fite BioPharma's total current liabilities against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.